AZN · Astrazeneca PLC · Investor Relations
Market Cap
$254.67B
Shares
1.55B
Volume · Oct 2
3.04M
Avg daily vol (3M)
3.41M
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-09-08 | Sustainability Highlights Call | Webcast |
| 2026-07-27 | Q2 FY2026 Earnings conference call (announced in 6-K) | Earnings call |
| 2026-04-29 | Q1 FY2026 Earnings conference call (announced in 6-K) | Earnings call |
| 2026-02-10 | Earnings conference call (announced in 6-K) | Earnings call |
| 2025-11-06 | Meet AZN Management: European Society for Medical Oncology (ESMO) 2025 | Webcast |
| 2024-11-15 | AstraZeneca Health Equity Investor Event | Event |
| 2023-11-09 | 9M and Q3 2023 results | Earnings call |
| 2022-12-08 | Meet AZN management: San Antonio Breast Cancer Symposium (SABCS) 2022 | Webcast |
| 2021-11-12 | Year-to-date and Q3 2021 results | Earnings call |
| 2020-12-12 | Accelerating AstraZeneca’s strategic and financial development: AstraZeneca to acquire Alexion | Webcast |
| 2019-12-10 | Investor science conference call: American Society of Hematology 2019 | Conference |
| 2018-12-13 | Year-end webcast for investors and analysts on China and Emerging Markets | Webcast |
Key facts
CIK
901832
CUSIP
G0593M107
13F (30d)
30 filings
26 filers
Visit website
Investor relations